Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody

Pathology International

Volumn 49, Issue 12, 1999, Pages 1067-1077

  Yoshinaga, Hidetoshi ^a   Matsuhashi, Sachiko ^a   Fujiyama, Chisato ^a   Masaki, Zenjiro ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

H731; Human gene; Nuclear antigen; PDCD4; Proliferation; Tumor cells

Indexed keywords

CELL NUCLEUS ANTIGEN; POLYCLONAL ANTIBODY; PROTEIN H731; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BLADDER CARCINOMA; BREAST CARCINOMA; BREAST EPITHELIUM; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; ESCHERICHIA COLI; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CELL DIVISION; CELL LINE, TRANSFORMED; EPITHELIAL CELLS; ESCHERICHIA COLI; FEMALE; FIBROBLASTS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS; PROTEINS; RNA-BINDING PROTEINS; TUMOR CELLS, CULTURED;

EID: 0033498486     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00995.x     Document Type: Article

References (28)

1. 1 Matsuhashi S, Watanabe T, Hori K. An antigen expressed in proliferating cells at G1-S phase. Exp. Cell Res. 1987; 170: 351-362.
2. 2 Matsuhashi S, Arai Y, Watanabe T, Hori K. Preparation of monoclonal antibodies against nuclear antigen in a DNA affinity purified protein fraction from chick embryo extract. Jpn J. Exp. Med. 1989; 59: 139-147.
3. 3 Matsuhashi S, Yoshinaga H, Yatsuki H, Tsugita A, Hori K. Isolation of a novel gene from a human cell line with Pr-28 MAb which recognizes a nuclear antigen involved in the cell cycle. Res. Commun. Biochem. Cell. Mol. Biol. 1997; 1: 109-120.
4. 4 Matsuhashi S, Hori K. Pr-28 antigen is localized in proliferating cell nuclei but absent from S phase nuclei. Res. Commun. Biochem. Cell. Mol. Biol. 1998; 2: 19-26.
5. 5 Soejima H, Miyoshi O, Yoshinaga H et al. Assignment of the programmed cell death 4 gene (PDCD4) to human chromosome band 10q24 in situ hybridization. Cytogenet. Cell Genet. (in press).
6. 6 Yoshinaga H, Matsuhashi S, Ahanek J, Masaki Z, Hori K. Expression and identification of H731 gene product in HeLa cells. Res. Commun. Biochem. Cell. Mol. Biol. 1997; 1: 121-131.
7. 7 Azzoni L, Zatsepina O, Abebe B, Bennett IM, Kanakaraj P, Rerussia B. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J. Immunol. 1998; 161: 3493-3500.
8. 8 Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjo T. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 1995; 166: 297-301.
9. 9 Jurisicova A, Latham KE, Casper RF, Varmuza SL. Expression and regulation of genes associated with cell death during murine preimplantation embryo development. Mol. Reprod. Dev. 1998; 51: 243-253.
10. 10 Onishi Y, Kizaki H. Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. Biochem. Biophys. Res. Commun. 1996; 228: 7-13.
11. 11 Cmarik JL, Min H, Hegamyer G et al. Novel differentially expressed protein inhibits tumor promoter-induced neoplastic transformation. Proc. Natl. Acad. Sci. USA 1999 (in press).
12. 12 Alberts B, Herrick G. DNA-cellulose chromatography. In: Grossman L, Moldave K, eds. Methods in Enzymology, vol. 21. Academic Press, New York 1971; 198-217.
13. 13 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
14. 14 O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975; 250: 4007-4402.
15. 15 Kitajima Y, Matsuhashi S, Nishida H et al. Monoclonal antibodies recognizing amino-terminal and carboxy-terminal regions of human aldolase A. Probes to detect conformational changes of the enzyme. J. Biochem. 1991; 109: 544-550.
16. 16 Harlow E, Lane D. Antibodies. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1988.
17. 17 Hynes RO, Destree AT. 10 nm filaments in normal and transformed cells. Cell 1978; 13: 151-163.
18. 18 Kozak M. Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles. Microbiol. Rev. 1983; 47: 1-45.
19. 19 Shine J, Dalgarno L. The 3′-terminal sequence of Escherichia coli 16S ribosomal RNA. Complementarity to nonsense triplets and ribosome binding sites. Proc. Natl Acad. Sci. USA 1974; 71: 1342-1346.
20. 20 Steitz JA, Jakes K. How ribosomes select initiator regions in mRNA. Base pair formation between the 3′ terminus of 16S rRNA and the mRNA during initiation of protein synthesis in Escherichia coli. Proc. Natl Acad. Sci. USA 1975; 72: 4734-4738.
21. 21 Dunn JJ, Buzash-Pollert E, Studier FW. Mutations of bacteriophage T7 that affect initiation of synthesis of the gene 0.3 protein. Proc. Natl Acad. Sci. USA 1978; 75: 2741-2745.
22. 22 Colburn NH, Former BF, Nelson KA, Yuspa SH. Tumour promoter induces anchorage independence irreversibly. Nature 1979; 281: 589-591.
23. 23 Colburn NH, Wendel EJ, Abruzzo G. Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: Mitogen-resistant variants are sensitive to promotion. Proc. Natl Acad. Sci. USA 1981; 78: 6912-6916.
24. 24 Cowell JK. The nuclear oncoproteins: RB and p53. Semin. Cancer Biol. 1990; 1: 437-446.
25. 25 Kovacs A, Weber ML, Burns LJ, Jacob HS, Vercellotti GM. Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. Am. J. Pathol. 1996; 149: 1531-1539.
26. 26 Merrick BA, He C, Witcher LL et al. HSP binding and mitochondrial localization of p53 protein in human HT1080 and mouse C3H10T1/2 cell lines. Biochim. Biophys. Acta 1996; 1297: 57-68.
27. 27 Ostermeyer AG, Runko E, Winkfield B, Ahn B, Moll UM. Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide. Proc. Natl Acad. Sci. USA 1996; 93: 15 190-15 194.
28. 28 Liang SH, Hong D, Clarke MF. Cooperation of a single lysine mutation and a C-terminal domain in the cytoplasmic sequestration of the p53 protein. J. Biol. Chem. 1998; 273: 19 817-19 821.